SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-20-014095
Filing Date
2020-12-31
Accepted
2020-12-31 17:21:12
Documents
4
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT vtgnpre14a_2020.htm PRE 14A 233127
2 IMAGE logo1.jpg GRAPHIC 6148
3 IMAGE logo2.jpg GRAPHIC 6265
4 IMAGE logo3.jpg GRAPHIC 6265
  Complete submission text file 0001654954-20-014095.txt   260344
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-37761 | Film No.: 201429484
SIC: 2834 Pharmaceutical Preparations